SEC Filing · 4/A
Edgewise Therapeutics, Inc.
EWTXNASDAQEQUITYCurrent
SEC Filing
Company context
Edgewise Therapeutics is a leading biopharmaceutical company focused on novel, muscle-targeted therapeutics. Leveraging its expertise in muscle biology and small molecule drug development, Edgewise is advancing a cardiovascular pipeline targeting significant unmet needs, including hypertrophic cardiomyopathy, heart failure and other serious cardiovascular and cardiometabolic conditions. To learn more, go to edgewisetx.com or follow Edgewise on LinkedIn, X, Facebook and Instagram.
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗